Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Jiangbei New Area State-owned Asset Management (NJJNA SAM) is a state-owned enterprise operating in Nanjing Jiangbei New Area, China. It focuses on urban development, infrastructure construction, public utilities, and industrial investment, including support for life sciences firms in the Nanjing Biotech & Pharmaceutical Valley, and has invested in biopharma companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Jiangbei New Area State-owned Asset Management.